AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

LATHAM, N.Y.--(BUSINESS WIRE)--Jul 28, 2025-

First subject enrolled in AngioDynamics’ atherectomy system study

AngioDynamics has enrolled the first subject in the AMBITION BTK trial designed to assess the Auryon Atherectomy System.The post First subject enrolled in AngioDynamics’ atherectomy system study appeared first on Medical Device Network.

AngioDynamics AMBITION BTK Trial Begins Enrollment - Endovascular Today

July 28, 2025—AngioDynamics, Inc. announced enrollment of the first patient in the AMBITION BTK study of the Auryon atherectomy system. According to the company, AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon system combined with standard balloon angioplasty versus balloon angioplasty alone in treating infrapopliteal lesions in patients wit…

AngioDynamics Enrolls First Patient in Trial for Treating Critical Limb Ischemia

Trial investigates the use of Auryon Atherectomy System in cases with challenging below-the-knee blockages.

First patient enrolled in AngioDynamics’ AMBITION BTK trial for CLTI - Interventional News

AngioDynamics today announced enrolment of the first patient in AMBITION BTK, a randomised study of the Auryon atherectomy system in patients with below-the-knee chronic limb-threatening ischaemia (CLTI). A press release details that AMBITION BTK is a prospective, multicentre, randomised controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon atherectomy system combined with standard balloon angioplasty…